Latest KFF Health News Stories
States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection
Pharmaceutical companies have put the brakes on many states’ ability to execute prisoners using lethal injections. Lacking alternatives, states are trying to keep the public from learning details about how they carry out executions.
$50 Billion in Opioid Settlement Cash Is on the Way. We’re Tracking How It’s Spent.
Spending the money effectively and equitably is a tall order for state and local governments, and a lack of transparency in the process is already leading to fears of misuse.
Montana Seeks to Insulate Nursing Homes From Future Financial Crises
Lawmakers are considering creating standards to set Medicaid reimbursement rates. But industry observers wonder whether the move would be too little, too late to bolster a beleaguered industry.
When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.
How Medicare Advantage Plans Dodged Auditors and Overcharged Taxpayers by Millions
Facing rare scrutiny from federal auditors, some Medicare Advantage health plans failed to produce any records to justify their payments, government records show. The audits revealed millions of dollars in overcharges to Medicare over three years.
Trickle of Covid Relief Funds Helps Fill Gaps in Rural Kids’ Mental Health Services
Only a sliver of the funding given to state, local, and tribal governments through the American Rescue Plan Act has been steered to mental health nationwide, but mental health advocates and clinicians hope the money it provides will help address gaps in care for children. In Appalachian Ohio, the funding is helping expand services.
Schools, Sheriffs, and Syringes: State Plans Vary for Spending $26B in Opioid Settlement Funds
The cash represents an unprecedented opportunity to derail the opioid epidemic, but with countless groups advocating for their share of the pie, the impact could depend heavily on geography and politics.
Medicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
Thousands of Experts Hired to Aid Public Health Departments Are Losing Their Jobs
As the covid-19 pandemic raged, an independent nonprofit tied to the Centers for Disease Control and Prevention hired an army of seasoned professionals to fill the gaps in the country’s public health system. Now, the money has largely run out, and state and local health departments are again without their expertise.
Abortion Issue Helps Limit Democrats’ Losses in Midterms
Although control of Congress was still undecided Wednesday, Republicans seemed poised to take power in the House, while the fate of the Senate remained too close to call. Economic issues were at the top of voters’ minds, but abortion access also played a large role in their decisions.
Listen: With Abortion Rights on the Ballot in Michigan, Women Tell Their Stories
Women who need abortion care come to Michigan from surrounding states that already have banned the procedure. A clinic in suburban Detroit allowed a reporter to interview patients, doctors, and nurses to understand what is at stake as voters decide whether to guarantee abortion access in the Michigan Constitution.
Centene Showers Politicians With Millions as It Courts Contracts and Settles Overbilling Allegations
Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.
Comienzan a estar disponibles audífonos de venta libre desde $199
Los audífonos de venta libre cuestan menos en parte porque no incluyen los servicios de un experto para una evaluación auditiva, ajuste y afinación del dispositivo. En cambio, los nuevos dispositivos deben ser configurados por los propios consumidores.
Say What? Hearing Aids Available Over-the-Counter for as Low as $199, and Without a Prescription
The cheaper over-the-counter aids are for adults with mild to moderate hearing loss — a market of tens of millions of people, many of whom have until now been priced out because prescription devices can cost thousands of dollars.
KHN’s ‘What the Health?’: Looking Ahead to the Lame-Duck Session
Congress won’t be back in Washington until after Election Day, but lawmakers have left themselves a long list of items to finish up in November and December, including unfinished health care policies. Sandhya Raman of CQ Roll Call; Jessie Hellmann, also of CQ Roll Call; and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Sam Whitehead, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a family who tried to use urgent care to save money, but ended up with a big emergency room bill anyway.
Centene to Pay $166 Million to Texas in Medicaid Drug Pricing Settlement
Texas is at least the 12th state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.
Médicos se apresuran a usar fallo de la Corte Suprema para liberarse de cargos por opioides
En una decisión de junio, el tribunal dijo que los fiscales no solo deben probar que una receta no estaba médicamente justificada sino también que el que la escribió sabía del riesgo de recetar opioides.
Doctors Rush to Use Supreme Court Ruling to Escape Opioid Charges
After a unanimous ruling from the high court, doctors who are accused of writing irresponsible prescriptions can go to trial with a new defense: It wasn’t on purpose.
Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedures
As private equity groups are swarming into aging America’s eye care, the consolidation is costing the U.S. health care system and patients more money.
Hospitals Divert Primary Care Patients to Health Center ‘Look-Alikes’ to Boost Finances
Medicare and Medicaid pay “look-alike” health centers significantly more than hospitals for treating patients, and converting or creating clinics can help hospitals reduce their expenses.
